Molly Henderson's Net Worth
$1.03 Million
Who is Molly Henderson?
Molly Henderson has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., Lion Biotechnologies, Inc., UroGen Pharma Ltd., Advaxis, Inc., and VirtualScopics, Inc..
SEC CIK
Molly Henderson's CIK is 0001363812
Past Insider Trading and Trends
2022 was Molly Henderson's most active year for acquiring shares with 8 total transactions. Molly Henderson's most active month to acquire stocks was the month of December. 2023 was Molly Henderson's most active year for disposing of shares, totalling 7 transactions. Molly Henderson's most active month to dispose stocks was the month of October. 2021 saw Molly Henderson paying a total of $39,625.00 for 30,500 shares, this is the most they've acquired in one year. In 2023 Molly Henderson cashed out on 24,160 shares for a total of $218,142.44, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.025
CFO and CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.48% | -3.44K |
$11.10 | -$38,128.50 | 95.26K |
Apr 8
| |||
Form 4
| -6.01% | -6.31K |
$7.75 | -$48,900.06 | 98.7K |
Jan 18 - Jan 19
| |||
Form 4
| -2.02% | -2.13K |
$7.24 | -$15,402.67 | 103.06K |
Nov 20
| |||
Form 4
| +10.51% | 10.01K |
$8.88 | -$110,870.75 | 105.19K |
Nov 1
| |||
Form 4/A
| +35.62% | 25K |
—
|
—
| 95.18K |
Jul 14
| |||
Form 4
| +35.62% | 25K |
$1.00 | $25,000.00 | 95.18K |
Jul 14
| |||
Form 4
| -2.78% | -1.96K |
$11.41 | -$22,367.72 | 68.51K |
Jun 2
| |||
Form 4
| -2.91% | -2.11K |
$12.87 | -$27,164.98 | 70.47K |
May 22
| |||
Form 4
| -4.52% | -3.44K |
$7.27 | -$25,001.53 | 72.58K |
Apr 6
| |||
Form 4
| -2.60% | -2.03K |
$8.53 | -$17,334.79 | 76.02K |
Scheduled
|
Mar 1
| ||
Form 4
| +73.26% | 33K |
—
|
—
| 78.05K |
Jan 19
| |||
Form 4
| -4.75% | -2.16K |
$9.60 | -$20,726.40 | 43.34K |
Nov 21
| |||
Form 4
| +19.74% | 7.5K |
—
|
—
| 45.5K |
Sep 1
| |||
Form 4
| +46.15% | 12K |
—
|
—
| 38K |
May 19
| |||
Form 4
| +30.00% | 6K |
—
|
—
| 26K |
May 13
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lion Biotechnologies, Inc. (IOVA) Snapshot price: $8.15
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1 - Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
UroGen Pharma Ltd. (URGN) Snapshot price: $15.76
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.82% | 335 |
$7.58 | -$2,508.98 | 5.25K |
Jan 31
| |||
Form 4
| +96.52% | 2.41K |
$12.03 | -$31,121.61 | 4.91K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 2.5K |
$15.85 | $39,625.00 | 2.5K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Advaxis, Inc. (ADXS) Snapshot price: $1.12
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
| +75.01% | 2.5K |
$3.68 | $9,199.75 | 5.83K |
Apr 11
| |||
Form 4
|
∞
| 3K |
$3.86 | $11,578.71 | 3K |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
|
∞
| 5K |
$1.89 | $9,450.00 | 5K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VirtualScopics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||